Literature DB >> 6337140

Proteolytic conversion of arginine-vasopressin and oxytocin by brain synaptic membranes. Characterization of formed peptides and mechanisms of proteolysis.

J P Burbach, J L Lebouille.   

Abstract

This study concerned the fragmentation of the nonapeptides arginine-vasopressin (AVP-(1-9)) and oxytocin (OXT-(1-9)) by proteolytic enzymes present in a brain synaptic membrane preparation. The peptides formed during digestion of arginine-vasopressin and oxytocin were isolated by high pressure liquid chromatography and chemically characterized by amino acid composition, NH2-terminal amino acid residues, and the presence of 14C radioactivity in tyrosine-2 and glycinamide-9. The major peptide fragments of arginine-vasopressin were [Cyt6]-AVP-(2-9), [Cyt6]-AVP-(3-9), [less than Glu4, Cyt6]-AVP-(4-9), and a peptide having the AVP-(4-8) sequence. The characterized fragments of oxytocin were [Cyt6]-OXT-(2-9), [Cyt6]-OXT-(3-9), [Cyt6]-OXT-(4-9), [less than Glu4, Cyt6]-OXT-(4-9), and [Cyt6] OXT-(5-9). Employing differentially 14C-labeled arginine-vasopressin and oxytocin, the proteolysis of the two peptides into fragments was followed with time. The results showed the sequential formation of peptide fragments by proteolytic cleavage from the NH2 terminus onward, demonstrating the action of an aminopeptidase-like enzyme. Arginine-vasopressin was converted significantly more rapidly by the amino-peptidase activity than oxytocin. In contrast to known brain aminopeptidases, the synaptic membrane-associated activity cleaved the nonapeptides without prior reduction of the disulfide bridge. From the present data it is concluded that aminopeptidases predominate in the proteolytic mechanism by which brain synaptic membranes convert arginine-vasopressin and oxytocin. The role of the proteolytic events and the significance of formed peptide fragments is discussed in view of the concept that arginine-vasopressin and oxytocin are precursors for neuropeptides in brain.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337140

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Abnormal hypothalamic oxytocin system in fibroblast growth factor 8-deficient mice.

Authors:  Leah R Brooks; Wilson C J Chung; Pei-San Tsai
Journal:  Endocrine       Date:  2010-07-10       Impact factor: 3.633

Review 2.  Molecular neurobiology and pharmacology of the vasopressin/oxytocin receptor family.

Authors:  J Peter; H Burbach; R A Adan; S J Lolait; F W van Leeuwen; E Mezey; M Palkovits; C Barberis
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

3.  Some mechanisms of action of vasopressin on animal behavior.

Authors:  S V Verevkina
Journal:  Neurosci Behav Physiol       Date:  1988 Jul-Aug

4.  Oxytocin retrogradely inhibits evoked, but not miniature, EPSCs in the rat supraoptic nucleus: role of N- and P/Q-type calcium channels.

Authors:  M Hirasawa; S B Kombian; Q J Pittman
Journal:  J Physiol       Date:  2001-05-01       Impact factor: 5.182

5.  Solubilization and purification of the Ni-stimulated arginine-vasopressin binding site of rat brain membranes.

Authors:  J T Junig; L G Abood
Journal:  Neurochem Res       Date:  1987-09       Impact factor: 3.996

6.  Mass spectrometric quantification of MIF-1 in mouse brain by multiple reaction monitoring.

Authors:  Indu Kheterpal; Abba J Kastin; Sahana Mollah; Chuanhui Yu; Hung Hsuchou; Weihong Pan
Journal:  Peptides       Date:  2009-04-11       Impact factor: 3.750

7.  Neuropeptides isotocin and arginine vasotocin in urophysis of three fish species.

Authors:  Magdalena Gozdowska; Marek Ślebioda; Ewa Kulczykowska
Journal:  Fish Physiol Biochem       Date:  2012-11-10       Impact factor: 2.794

Review 8.  Peptidome: Chaos or Inevitability.

Authors:  Irina Lyapina; Vadim Ivanov; Igor Fesenko
Journal:  Int J Mol Sci       Date:  2021-12-04       Impact factor: 5.923

Review 9.  The Effects of Oxytocin on Appetite Regulation, Food Intake and Metabolism in Humans.

Authors:  Liya Kerem; Elizabeth A Lawson
Journal:  Int J Mol Sci       Date:  2021-07-20       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.